• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[酶联免疫吸附测定法检测血浆中SC5b-9水平及其在系统性红斑狼疮疾病中的临床意义]

[ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].

作者信息

Kan D

机构信息

Institute of Basic Medical Sciences, CAMS and PUMC, Beijing.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Aug;15(4):302-5.

PMID:8168211
Abstract

Using IgG from rabbit antiserum to human MAC neoantigens and SC5b-9, we established a sandwich ELISA for detecting SC5b-9 levels in human plasma. SC5b-9 was measured in 51 normal plasma samples and 40 plasma samples from patients with SLE. We found that SC5b-9 levels in 96.1% of the controls and in 78.9% of the patients with inactive SLE were below 450 ng/ml, while SC5b-9 levels in 81.0% of the patients with active SLE were above 450 ng/ml. This shows that SC5b-9 levels may be useful for diagnosing patients with clinically active SLE.

摘要

我们使用兔抗人膜攻击复合物(MAC)新抗原和SC5b - 9的抗血清中的IgG,建立了一种夹心酶联免疫吸附测定法(ELISA),用于检测人血浆中的SC5b - 9水平。对51份正常血浆样本和40份系统性红斑狼疮(SLE)患者的血浆样本进行了SC5b - 9检测。我们发现,96.1%的对照组和78.9%的非活动期SLE患者的SC5b - 9水平低于450 ng/ml,而81.0%的活动期SLE患者的SC5b - 9水平高于450 ng/ml。这表明SC5b - 9水平可能有助于诊断临床活动期SLE患者。

相似文献

1
[ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].[酶联免疫吸附测定法检测血浆中SC5b-9水平及其在系统性红斑狼疮疾病中的临床意义]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Aug;15(4):302-5.
2
Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.风湿性疾病患者血浆和滑液中SC5b-9补体复合物的水平。
Med Interne. 1990 Oct-Dec;28(4):305-10.
3
SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.SC5b-9是评估巴西系统性红斑狼疮患者疾病活动度时最敏感的标志物。
J Investig Allergol Clin Immunol. 1998 Jul-Aug;8(4):239-44.
4
In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.兔体内终末液相补体复合物的清除研究。
Clin Exp Immunol. 1989 Jul;77(1):112-6.
5
Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.检测原发性干燥综合征或系统性红斑狼疮累及中枢神经系统患者脑脊液中活化的终末补体(C5b-9)。
J Immunol. 1987 Apr 1;138(7):2095-9.
6
[Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].肾小球疾病患者血浆和尿液中终末补体复合物(TTC)水平:使用抗TCC新抗原单克隆抗体的酶联免疫吸附测定(ELISA)
Hokkaido Igaku Zasshi. 1990 Jan;65(1):74-85.
7
Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.系统性红斑狼疮患者血浆中催乳素的分子异质性
Arthritis Rheum. 2001 Jun;44(6):1331-5. doi: 10.1002/1529-0131(200106)44:6<1331::AID-ART225>3.0.CO;2-Q.
8
Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.系统性红斑狼疮患者血清中补体攻膜复合物的放射免疫测定
N Engl J Med. 1985 Jun 20;312(25):1594-9. doi: 10.1056/NEJM198506203122502.
9
Usefulness of detection of complement activation products in evaluating SLE activity.补体激活产物检测在评估系统性红斑狼疮活动度中的应用价值。
Lupus. 2000;9(1):19-25. doi: 10.1177/096120330000900105.
10
Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.系统性红斑狼疮中的淋巴细胞毒性抗体与疾病活动相关,无论是否存在神经精神表现。
Scand J Rheumatol. 2007 Nov-Dec;36(6):442-7. doi: 10.1080/03009740701482768.